Short Interest in ResMed Rises 17.2%

Approximately 8.2% of the company's stock are now sold short

Mar. 17, 2026 at 8:19am

Got story updates? Submit your updates here. ›

ResMed Inc. (NYSE:RMD) saw a significant increase in short interest during February, with the number of shares sold short growing 17.2% to 11,837,993. This represents about 8.2% of the company's outstanding shares. Based on the average daily trading volume of 965,467 shares, the current short interest ratio is 12.3 days.

Why it matters

The rise in short interest suggests some investors are betting against ResMed's stock performance in the near term. Short selling activity can be an indicator of market sentiment and expectations around a company's future prospects.

The details

The increase in short interest occurred between February 12th and February 27th. ResMed is a medical device company that focuses on sleep apnea and respiratory care products. The company has seen its stock price fluctuate in recent months as it navigates supply chain challenges and changing demand patterns.

  • As of February 27th, 2023, there was short interest totaling 11,837,993 shares.
  • This represents a 17.2% increase from the 10,098,338 shares that were short as of February 12th, 2023.

The players

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The rise in short interest in ResMed's stock suggests some investors are anticipating potential challenges or downside for the company in the near future, though the overall market sentiment remains mixed. The situation will likely continue to evolve as ResMed navigates industry dynamics and market conditions.